BioSpace News Archive

Improvements to individual insurance market would provide access to coverage to 4.2 million more people

BirchBioMed Inc., a clinical-stage biomedical company focused on the clinical evaluation, development and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation, announces that the first subjects have been enrolled in its study with FS2 for the reduction of keloid scars.

The consumer digital heath fund, a member of CK Hutchison Holdings Group, invests in ventures at the intersection of healthcare and retail

A recent high-profile sting operation in Florida highlighted the tragedy of human trafficking conducted by illegitimate massage therapy operators.

Aesculap Biologics, LLC announced that it has successfully achieved 50 percent enrollment in the ongoing Phase 3 clinical trial of NOVOCART® 3D, an autologous chondrocyte transplantation system designed to treat articular cartilage defects of the knee.

When Auburn University senior Cassie Bebout was 6 years old, her 9-year-old brother Jake died from GM1, a rare genetic disease with no cure.

General Manager of Healthcare at FairWarning Invited to Participate in Panel to Help Covered Entities Navigate Regulatory Requirements with New Business Associates

Secretary of Health and Human Services to speak to kidney patients and families at the Kidney Patient Summit

Upgrades to Award-Winning Orbita Voice™ Platform Deliver Enterprise-Grade, End-to-End Functionality to Design, Build, Manage and Optimize Conversational Experiences

APT will offer a broad portfolio and oral drug delivery technology platforms, including Bioavailability, as well as enhanced and customized drug release.